About Somahlution
Somahlution: Revolutionizing Biotechnology for Advanced Human Health
Somahlution is a privately-held global biotechnology company headquartered in Jupiter, Florida that has been revolutionizing the field of biotechnology with its innovative products and solutions. The company is dedicated to developing and marketing advanced healthcare products that improve the quality of life for people around the world.
At Somahlution, we believe that innovation is key to advancing human health. Our team of experts works tirelessly to develop cutting-edge technologies and solutions that address some of the most pressing healthcare challenges facing society today. We are committed to improving patient outcomes by providing safe, effective, and affordable treatments.
One of our flagship products is DuraGraft – a revolutionary solution for cardiovascular surgery. DuraGraft is a vascular graft treatment designed to improve long-term outcomes in coronary artery bypass graft (CABG) surgery patients. It works by reducing oxidative stress during surgery, which can lead to better graft patency rates and improved clinical outcomes.
DuraGraft has been extensively tested in clinical trials and has demonstrated significant benefits over traditional CABG procedures. It has been shown to reduce postoperative complications such as myocardial infarction (MI), stroke, renal failure, respiratory failure, sepsis, wound infections, atrial fibrillation (AF), bleeding complications requiring transfusion or reoperation.
In addition to DuraGraft product line Somahlution also offers other innovative healthcare solutions including:
- VascuStim: A non-invasive device designed for patients with peripheral arterial disease (PAD). VascuStim uses electrical stimulation therapy to promote blood flow in affected areas.
- OxyFend: A topical wound care solution designed for use on chronic wounds such as diabetic foot ulcers or pressure sores.
- ProxiCor: A dietary supplement formulated with natural ingredients known for their anti-inflammatory properties.
At Somahlution we are committed not only to developing innovative products but also ensuring they are accessible globally at an affordable price point without compromising on quality standards. We work closely with regulatory authorities worldwide ensuring compliance with all applicable regulations while maintaining high ethical standards throughout our operations.
Our team comprises highly skilled professionals from diverse backgrounds who share a passion for improving human health through innovation. We foster an environment where creativity thrives; this enables us always stay ahead of the curve when it comes down developing new technologies or refining existing ones.
In conclusion,
Somahlution's mission statement "Revolutionizing Biotechnology For Advanced Human Health" speaks volumes about what they stand for - Innovation! They have made significant strides towards achieving this goal through their groundbreaking research into cardiovascular surgery techniques like CABG using DuraCraft technology which reduces oxidative stress during surgeries leading better patient outcomes post-surgery compared traditional methods used before its introduction into medical practice globally making them one-of-a-kind biotech companies out there today!